ALBUQUERQUE, N.M.

A special conference is being held this Sunday at the Jewish Community Center of Greater Albuquerque to help the public learn more about their health care options.

The conference is being held from 9:30 a.m. to 4 p.m. Tickets will cost $25 and include lunch.

Speakers will talk about BRCA-related cancers, genetic conditions and DNA testing.

The JCC is located at 5520 Wyoming Blvd. NE.

Click here for more details.

Here is the original post:
Second annual Jewish Genetics/DNA Conference - KOAT Albuquerque

(Story being updated)

SALEM, Ohio Two of the nations largest genetic companies for dairy and beef breeders have announced plans to merge.

The board of directors for Select Sires, based in Plain City, Ohio, and Accelerated Genetics, based in Baraboo Wisconsin, have both reached a unanimous decision to unite the two cooperatives.

According to the agreement, Select Sires will acquire the assets of Accelerated Genetics, joining employees and independent sales representatives.

The two entities have been working closely together since 2001, when a collaborative agreement made them both owners of World Wide Sires the international marketing arm for both companies in Europe, Africa, Asia, the Middle East and Oceania.

Shirley Kaltenbach, director of communications for Select Sires, said both organizations have the same goals and both have the same cooperative business structure and business principals.

She said both entities will continue to operate under the same names until a long-term strategy is reached. Accelerated Genetics still needs the approval at its June 22 delegate meeting, but she said the outcome is looking positive.

Accelerated Genetics has about 250 employees and works with an additional 180 independent sales representatives, said Angie Lindloff, vice president of marketing and communications.

She said the merger provides more opportunity for both customers and employees.

Joining forces gives us huge opportunity for our genetic lineup, Lindloff said. It helps everybody and it will allow us to serve our customers better.

Lindloff expects the current Accelerated Genetics facilities will remain operational, including the bull facility and main office.

Kaltenbach said Select Sires will continue to be located in Plain City. She said the goal will be to retain as many employees from both organizations as possible, but positions will be evaluated.

This impending endeavor will create a well-rounded genetics program and solutions-based animal health care product line that will fit the needs of dairy and beef producers worldwide, according to the release.

Select Sires bills itself as North Americas largest artificial insemination organization and is comprised of nine farmer-owned and controlled cooperatives.

Accelerated Genetics is a producer-owned cooperative, with solutions focussed on genetics and value-added products, programs and services for dairy and beef customers worldwide.

Up-to-date agriculture news in your inbox!

See the article here:
Select Sires to acquire Accelerated Genetics - Farm and Dairy

ATLANTA - You could call 23andMe a test for the genetically-curious.

For $199, you can find out what your genes reveal about not just your ancestry and your traits, but your health.

Dr. Jeffrey Pollard, Director of Medical Affairs for 23andMe says 2 million people have already taken the test.

"I think it's exciting to learn something about yourself," Dr. Pollard says. "Everyone likes learning new things about themselves."

The process is pretty simple.

You order the kit, collect a sample of your saliva and send it off to 23andMe.

A few weeks later, through an online portal, you can read you genetic health risk test results, and find out if you might be at higher risk of developing certain diseases like late-onset Alzheimer's Disease and Parkinson's Disease.

But genetics testing in relatively new, says Pollard, and there are limits to what 23andMe can reveal.

"We are not a diagnostic test," Pollard cautions. "So, we aren't telling anyone the have a certain condition. We're really presenting them with an element of their genetic risk, if you will."

Kimberly King-Spohn, Director of the WellStar Center for Genetics, says at least a third of her patients have mentioned 23andMe since April, when the US Food and Drug Administration cleared the direct-to-consumer genetic testing company to offer health risk information to consumers for 10 disease and conditions.

King-Spohn has some concerns.

"It's confusing," she says. "They get a very long report with a lot of information, and patients have had a difficult time interpreting what that means for their health."

Dr. Pollard says 23andMe provides a lot of context, to help customers make sense of their findings.

But, King-Spohn argues patients may not want to know they're at higher genetic risk of developing diseases they can't really do anything about.

"We don't have a treatment or intervention for Alzheimer's disease," she says. "So, what would you do with that information?"

Pollard says the information 23andMe offers is just a piece of a much larger puzzle.

"We like to highlight the fact that your genetic risk is just one element in play," he says.

Because, Pollard says, there are a lot of factors you can control, when it comes to your health.

"You might be able to change certain other things that you do in your life, whether it's exercise, or your activity level, your diet, whether or not you smoke," he says.

Both Pollard and King-Spohn agree it's important to read the fine print, before you get screened, to make sure you understand what 23andMe can and cannot tell you.

It's a lot to absorb, they both say.

"But it's also empowering" Dr. Pollard says. "And, we hear that our customers are taking this information and doing something with it in their lives. So, that, I think, is a very powerful beginning."

See the rest here:
At-home genetic test reveals secrets about your health - FOX 5 Atlanta

Tufts University will continue to teach local students about the possibilities of genetics work thanks to a $100,000 grant from Cummings Foundation.

Tufts University's popular Bioinformatics Inquiry through Sequencing (BioSeq) program will continue to teach local students about the possibilities of genetics work thanks to a $100,000 grant from Cummings Foundation.

BioSeq uses an interactive curriculum that emphasizes the value of genetics in personally relevant contexts, preparing students for research careers and enhancing understanding of how genetics work can shape and save lives.

The BioSeq program is part of Tufts and Cummings Foundation's legacy of support for science, technology, engineering and mathematics (STEM) education opportunities for students in greater Boston.

Started with funding from the National Institutes of Health Science Education Partnership Award and now in its fifth year, BioSeq has reached over 1,000 students in Medford, Somerville and Malden schools.

Until recently, genetic sequencing was labor-intensive, slow and expensive. Thanks to next-generation sequencing, however, scientists are employing new tools to gather genetic data and to draw meaningful conclusions on how the data can push the boundaries of medical knowledge and bring the promise of personalized medicine closer to reality. Despite these tremendous advances, this technology is largely out of the reach of the high school audience.

Due to cost and curriculum restraints, students in low-income and diverse urban communities often have limited opportunities to interact with genetics science, though within their lifetimes, current high school students will have to understand how their genetics may influence the treatments they receive and the drugs they are prescribed. The BioSeq program works to expose students to the possibilities of genetic sequencing so they will be more comfortable and better informed as genomics plays an increasingly influential role in health and medicine.

BioSeq engages and challenges students in their high school classrooms by focusing on inquiry-based experiments that relate to them directly. This grant will enable the program to continue to support classroom experiments such as "The Microbiome Portrait Experiment" in which students analyze their own DNA as well as local students and classes with their genomic science fair projects and will provide scholarships for the BioSeq summer program, run by Tufts Summer Studies.

"We're very grateful for Cumming Foundation's generosity and its continued commitment to both Tufts University and the goal of enhancing STEM education for young students from our local communities. Because of Cummings Foundation's support, students will have opportunities to learn by asking and answering their own questions about genetics," said Matthew Fierman, Ph.D., BioSeq's program administrator.

Cummings Foundation, Inc., founded by Tufts alumnus and trustee emeritus Bill Cummings and his wife, Joyce Cummings, has awarded more than $170 million in grants to non-profit organizations serving a broad range of causes in greater Boston and around the world, including human services, education, health care, and social justice. Cummings Foundation is active internationally through aid to the post-genocide rebuilding of Rwanda and support of education to help prevent future genocides and other intercultural violence and injustice. The Cummings' philanthropy has had a significant impact on the Tufts community in particular, including a naming gift in support of Cummings School of Veterinary Medicine at Tufts University.

For more information about the BioSeq program, including sample classroom activities, please visit: http://ase.tufts.edu/chemistry/walt/sepa/index.html

View original post here:
Cummings grants Tufts $100K to bolster genetics program - Wicked Local Medford

Subscribe today for full access on your desktop, tablet, and mobile device.

Let friends in your social network know what you are reading about

Select Sires will acquire the assets of Accelerated Genetics, joining forces of employees and independent sales representatives.

Try Another

Audio CAPTCHA

Image CAPTCHA

Help

CancelSend

A link has been sent to your friend's email address.

A link has been posted to your Facebook feed.

Wisconsin State Farmer 4:57 p.m. CT June 13, 2017

Select Sires Inc., and Accelerated Genetics will join forces this summer.(Photo: Select Sires Inc.)

BARABOO, WI - Two well known A.I. organizations will join forces this summer.

The board of directors for Select Sires Inc., and Accelerated Genetics reached a unanimous decision to unify the two cooperatives. Under the planned agreement, Select Sires will acquire the assets of Accelerated Genetics, joining together employees and independent sales representatives in each of their geographical member organizations.

This decision coincides with an already collaborative business relationship that began in 2001, where each shares ownership of World Wide Sires, Ltd. World Wide Sires serves as the international marketing arm for both companies in Europe, Africa, Asia, the Middle East and Oceania.

On June 22, 2017, Accelerated Genetics delegates will come together to cast the final vote on the direction of the cooperative. The goal is to create a unified cooperative that is second-to-none in the market place dedicated to the producer, according to company officials.

This impending endeavor is expected to create a well-rounded genetics program and solution-based animal health care product line that will fit the needs of dairy and beef producers worldwide. Producers can expect to continue working with highly qualified, passionate individuals, who know and understand the cattle breeding industry.

Based in Plain City, OH, Select Sires Inc. is North Americas largest A.I. organization and is comprised of nine farmer-owned and -controlled cooperatives

Read or Share this story: http://www.wisfarmer.com/story/news/state/2017/06/13/select-sires-inc-and-accelerated-genetics-join-forces/394333001/

Excerpt from:
Select Sires Inc., and Accelerated Genetics to join forces - Wisconsin State Farmer

Cystic fibrosis is a common genetic disease, relatively speaking. About one in 25 to 30 Caucasians are carriers of a cystic fibrosis mutation. But there are more than 1,700 mutations of the cystic fibrosis gene that can result in different disease symptoms.

Researchers and companies working on cystic fibrosis treatments are increasingly paying attention to which mutations a patient carries, and tailoring drugs to certain mutations.

Just recently, the FDA expanded its approval for one cystic fibrosis drug called Kalydeco. It had been approved for use in the case of ten of the mutations. Now its approved for 33.

They did it without a full clinical trial. The reason: each mutation is so rare, there just arent the hundreds of people a lab needs to do a clinical drug trial.

You just cant do it, said Art Caplan, Professor of Bioethics at New York University's Langone Medical Center.

Some of the things we usually see, like a randomized trial with hundreds or thousands of subjects, are not going to work because of the ability to pick out genetic differences among subjects, making it harder to do the big studies, he said.

Another fundamental shift in this area of medicine has to do with how drugs are used. Labs are now investigating how a the same drug might treat a wide range of maladies.

Some diseases that we dont even think of as related -- lets say, ALS, muscular dystrophy, and severe depression they may turn out to have the same chemical pathway that you can block with a drug, Caplan said.

It is huge and it is the future.

Originally posted here:
Discoveries in Genetics Are Changing the Way Drugs Are Tested - WCAI

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Read this article:
Genetics: Recipe for intelligence - Nature.com

Sessions/Tracks

ConferenceSeries LLC provides the perfect platform for global networking and we are truly delighted to invite you to attend our 9thInternational Conference on Genomics & Pharmacogenomics, during June 15-16, 2017London, UK. Genomics-2017 is a global platform to discuss and learn about Genomics & Pharmacogenomics and its allied areas Bioinformatics, Transcriptomics, Biotechnology, Molecular Biology, Molecular Genetics and Genetic Engineering.

Track 1:Cancer Genomics

TumorGenomicsis the investigation ofhereditarytransformationsin charge of malignancy, utilizinggenomesequencingandbioinformatics. Diseasegenomicsis to enhance growth treatment and results lies in figuring out which sets of qualities and quality associations influence diverse subsets of tumors. UniversalCancer GenomeConsortium (ICGC) is a deliberate experimental association that gives a discussion to joint effort among the world's driving growth andgenomic analysts.

RelatedConferences:

5th InternationalConference on Integrative BiologyJune 19-21, 2017 London, UK; InternationalConference onGenetic Counseling and Genomic Medicine,December 07-08, 2016 Madrid, Spain; 9th InternationalConference on Genomics and PharmacogenomicsJuly 13-14, 2017 Chicago, USA;Conference onSynthetic Biology: Engineering, Evolution & Design (SEED), June 20-23, 2017 Hyatt Regency, Vancouver, British Columbia, Canada. 28th Annual Lorne Genomics Conference 2017 February 12-14, 2017 Mantra Lorne, Victoria, Australia. 29th Fungal Genetics conference March 14-19, 2017 Pacific Grove, CA

Related Societies:

Canadian Association of Genetic Counsellors, Canada. European Cytogeneticists Association, Europe. Human Genome Organisation, South Korea. Biochemistry Moroccan Society and Molecular Biology, Africa, Federation of African societies of Biochemistry & Molecular Biology, Kenya. South African Stem Cell Transplantation Society, South Africa. National Society of Genetic Counselors, Chicago. Canadian College of Medical Geneticists, Canada. German Society of Human Genetics, Germany.

Track 2:Functional Genomics

UtilitarianGenomicsuse incomprehensible abundance of information created bygenomic transcriptomictasks to portray quality capacities and cooperations. Patterns inFunctional Genomicsare Affymetrix developed as an early trend-setter around there by imagining a commonsense approach to examine quality capacity as a framework.

RelatedConferences:

6th International Conference onTissue Engineering &Regenerative Medicine,Baltimore, USA,Aug 20-22, 2017; 8th World Congress and Expo onCell &Stem Cell Research,Orlando, USA,March 20-22, 2017; 15thWorld Congress onBiotechnologyand Biotech Industries Meet,Rome, Italy,March 20-21, 2017; 2nd International Conference onGenetic Counselling andGenomic Medicine,Beijing, China, July 10-12, 2017; International Conference onClinical andMolecular Genetics,Las Vegas, USA,April 24-26, 2017. Internation Plant and Animal Conference XXV January 14-18, 2017 San Diego, CA, USA. Plant Genomics and Gene Editing Congress Conference Asia April 10-11, 2017 Hong Kong.

Related Societies:

Swiss Society of Medical Genetics, Switzerland. Human Variome Project, Australia. American College of Medical Genetics and Genomics, USA. International Federation of Human Genetics Societies, South Africa. Human Genetics Society of Australasia, Australia. Belgian Society for Human Genetics, Belgian. Asia Pacific Society of Human Genetics, Asia.

Track 3:Next Generation Sequencing

Cutting edge sequencing(NGS) is regularly alluded to as greatly parallel sequencing, which implies that a large number of little parts ofDNAcan be sequenced in the meantime, making a gigantic pool of information. Cutting edge sequencing (NGS), hugely parallel or profound sequencing is connected terms that portray aDNA sequencinginnovation which has upsetgenomic research.

RelatedConferences:

2nd International Conference onMolecular Biology, London, UK,June 22-24, 2017;3rd WorldBioSummit & Expo, Abu Dhabi, UAE,June 19-21, 2017;5th International Conference onIntegrativeBiology, London, UK,June 19-21, 2017;2nd World Congress on HumanGenetics, Chicago, USA,July 24-26, 2017;9th International Conference onGenomicsand Pharmacogenomics, London, UK,June15-16, 2017. 28thAnnual Lorne Genomics Conference2017 February 12-14.

Related Societies:

International Federation of Human Genetics Societies, South Africa. Europe. Human Genome Organisation, South Korea. National Society of Genetic Counselors, Chicago. Canadian College of Medical Geneticists, Canada. International Federation of Human Genetics Societies, South Africa. Human Genetics Society of Australasia, Australia. German Society of Human Genetics, Germany.

Track 4:Biomarkers & Molecular Markers

Biomarkerscan be trademark organic properties or particles that can be distinguished and measured in parts of the body such as the blood or tissue.Biomarkerscan be particular cells, atoms, or qualities, quality items, chemicals, orhormones.Atomicmarkeris a section of DNA that is connected with a specific area inside of thegenome. Atomic markers are utilized as a part of sub-atomic science andbiotechnologyto distinguish a specific grouping of DNA in a pool of obscure DNA.

RelatedConferences:

7th International Conference onPlantGenomics,Bangkok, Thailand,July 03-05, 2017; 15th EuroBiotechnologyCongress,Valencia, Spain,June 05-07, 2017; International Conference onIntegrative Medicine& Nutrition,Dubai, UAE,May11-13, 2017; 14th Asia-PacificBiotechCongress, April 10-12, 2017; Beijing, China,15thBiotechnologyCongress,Baltimore, USA,June 22-23, 2017. 29thFungal Genetics conferenceMarch 14-19, 2017 Pacific Grove, CA.

Related Societies:

Canadian Association of Genetic Counsellors, Canada.European Cytogeneticists Association, Europe.Human Genome Organisation, South Korea.Biochemistry Moroccan Society and Molecular Biology, Africa,Federation of African societies of Biochemistry & Molecular Biology, Kenya.South African Stem Cell Transplantation Society, South Africa.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.German Society of Human Genetics, Germany.

Track: 5Pharmacogenomics & Personalized Medicine

Pharmacogenomicsis a piece of a field called customized solution that means to tweak human services, with choices and medications custom-made to every individual patient inside and out conceivable.Pharmacogenomicsandpharmacogenomicsmanages new developments in the field of customized meds and advancements in modified medication revelation utilizingproteomeinnovation.

RelatedConferences:

5th International Conference and Exhibition onCell and Gene Therapy,Madrid, Spain, Mar 2-3, 2017;International Conference onCell Signalling andCancer Therapy,Paris, France,Aug 20-22, 2017; 7th Annual Conference onStem Celland Regenerative Medicine,Paris, France,Aug 04-05, 2016;3rd International Conference & Exhibition onTissue Preservationand Bio banking,Baltimore, USA,June 29-30, 2017.Internation Plant and Animal Conference XXVJanuary 14-18, 2017 San Diego, CA, USA.

Related Societies:

Swiss Society of Medical Genetics, Switzerland.Human Variome Project, Australia.American College of Medical Genetics and Genomics, USA.International Federation of Human Genetics Societies, South Africa.Human Genetics Society of Australasia, Australia.Belgian Society for Human Genetics, Belgian.Asia Pacific Society of Human Genetics, Asia.

Track 6:Clinical Genomics

Clinical Genomicsis the utilization of genome sequencing to educate understanding analysis and care.Genome sequencingis relied upon to have the most effect in: portraying and diagnosinghereditary infection; stratifying patients for fittingmalignancytreatment; and giving data around an individual'simaginable reactionto treatment to lessen antagonistic medication responses.

RelatedConferences:

6th International Conference onTissue Engineering &Regenerative Medicine,Baltimore, USA,Aug 20-22, 2017; 8th World Congress and Expo onCell &Stem Cell Research,Orlando, USA,March 20-22, 2017; 15thWorld Congress onBiotechnologyand Biotech Industries Meet,Rome, Italy,March 20-21, 2017; 2nd International Conference onGenetic Counselling andGenomic Medicine,Beijing, China, July 10-12, 2017; International Conference onClinical andMolecular Genetics,Las Vegas, USA,April 24-26, 2017.Plant Genomics and Gene Editing CongressConference Asia April 10-11, 2017 Hong Kong.

Related Societies:

International Federation of Human Genetics Societies, South Africa.Europe. Human Genome Organisation, South Korea.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.International Federation of Human Genetics Societies, South Africa.Human Genetics Society of Australasia, Australia.German Society of Human Genetics, Germany.

Track 7:Micro RNA

MicroRNAscomprise a novel class of small, non-coding endogenous RNAs that regulategene expressionby directing their targetmRNAsfor degradation or translational repression. miRNAs represent smallRNA moleculesencoded in thegenomesofplantsand animals. These highly conserved 22 nucleotides longRNA sequencesregulate the expression of genes by binding to the 3'-untranslated regions (3'-UTR) of specific mRNAs. A growing body of evidence shows that mRNAs are one of the key players in cell differentiation and growth, mobility andapoptosis.

RelatedConferences:

2nd International Conference onMolecular Biology, London, UK,June 22-24, 2017;3rd WorldBioSummit & Expo, Abu Dhabi, UAE,June 19-21, 2017;5th International Conference onIntegrativeBiology, London, UK,June 19-21, 2017;2nd World Congress on HumanGenetics, Chicago, USA,July 24-26, 2017;9th International Conference onGenomicsand Pharmacogenomics, London,UK,June 15-16, 2017. 28thAnnual Lorne Genomics Conference2017 February 12-14, 2017 Mantra Lorne, Victoria, Australia.

Related Societies:

Canadian Association of Genetic Counsellors, Canada.European Cytogeneticists Association, Europe.Human Genome Organisation, South Korea.Biochemistry Moroccan Society and Molecular Biology, Africa,Federation of African societies of Biochemistry & Molecular Biology, Kenya.South African Stem Cell Transplantation Society, South Africa.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.German Society of Human Genetics, Germany.

Track 8:mRNA Analysis

mRNAis a subtype of RNA. AmRNAatom conveys a segment of the DNA code to different parts of the cell for preparing.mRNAis made amid interpretation. Amid the translation handle, a solitary strand ofDNAis decoded by RNA polymerase, and mRNA is incorporated. Physically, mRNA is a strand of nucleotides known asribonucleiccorrosive, and is single-stranded.

RelatedConferences:

7th International Conference onPlantGenomics,Bangkok, Thailand,July 03-05, 2017; 15th EuroBiotechnologyCongress,Valencia, Spain,June 05-07, 2017; International Conference onIntegrative Medicine& Nutrition,Dubai, UAE,May11-13, 2017; 14th Asia-PacificBiotechCongress, April 10-12, 2017; Beijing, China,15thBiotechnologyCongress,Baltimore, USA,June 22-23, 2017. 29thFungal Genetics conferenceMarch 14-19, 2017 Pacific Grove, CA.

Related Societies:

Swiss Society of Medical Genetics, Switzerland.Human Variome Project, Australia.American College of Medical Genetics and Genomics, USA.International Federation of Human Genetics Societies, South Africa.Human Genetics Society of Australasia, Australia.Belgian Society for Human Genetics, Belgian.Asia Pacific Society of Human Genetics, Asia.

Track9:BioinformaticsinGenomics

Bioinformaticsis the exploration of gathering and breaking down complex organic information, for example,hereditary codes. Sub-atomic solution requires the joining and examination of genomic, sub-atomic, cell, and additionallyclinical informationand it in this way offers a momentous arrangement of difficulties to bioinformatics.

RelatedConferences:

5th International Conference and Exhibition onCell and Gene Therapy,Madrid, Spain, Mar 2-3, 2017;International Conference onCell Signalling andCancer Therapy,Paris, France,Aug 20-22, 2017; 7th Annual Conference onStem Celland Regenerative Medicine,Paris, France,Aug 04-05, 2016;3rd International Conference & Exhibition onTissue Preservationand Bio banking,Baltimore, USA,June 29-30, 2017.Internation Plant and Animal Conference XXVJanuary 14-18, 2017 San Diego, CA, USA.

Related Societies:

International Federation of Human Genetics Societies, South Africa.Europe. Human Genome Organisation, South Korea.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.International Federation of Human Genetics Societies, South Africa.Human Genetics Society of Australasia, Australia.German Society of Human Genetics, Germany.

Track 10:Comparative Genomics

SimilarGenomicsandgenomicmedicinenewfieldofnaturalexaminationinwhichthegenomegroupins of variousspecies- human, mouse and a wide assortment of different life forms from yeast to chimpanzees-are looked at. The assessment of likenesses and contrasts betweengenomesof various life forms; can uncover contrasts in the middle of people and species and also transformative connections.

RelatedConferences:

6th International Conference onTissue Engineering &Regenerative Medicine,Baltimore, USA,Aug 20-22, 2017; 8th World Congress and Expo onCell &Stem Cell Research,Orlando, USA,March 20-22, 2017; 15thWorld Congress onBiotechnologyand Biotech Industries Meet,Rome, Italy,March 20-21, 2017; 2nd International Conference onGenetic Counselling andGenomic Medicine,Beijing, China, July 10-12, 2017; International Conference onClinical andMolecular Genetics,Las Vegas, USA,April 24-26, 2017.Plant Genomics and Gene Editing CongressConference Asia April 10-11, 2017 Hong Kong.

Related Societies:

Canadian Association of Genetic Counsellors, Canada.European Cytogeneticists Association, Europe.Human Genome Organisation, South Korea.Biochemistry Moroccan Society and Molecular Biology, Africa,Federation of African societies of Biochemistry & Molecular Biology, Kenya.South African Stem Cell Transplantation Society, South Africa.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.German Society of Human Genetics, Germany.

Track 11:Plant Genomics

Late mechanical headways have generously extended our capacity to dissect and comprehendplantgenomesand to diminish the crevice existing in the middle of genotype and phenotype. The quick advancing field of genomics permits researchers to dissect a huge number of qualities in parallel, to comprehend the hereditary building design ofplant genomesfurthermore to separate the qualities in charge oftransformations.

RelatedConferences:

2nd International Conference onMolecular Biology, London, UK,June 22-24, 2017;3rd WorldBioSummit & Expo, Abu Dhabi, UAE,June 19-21, 2017;5th International Conference onIntegrativeBiology, London, UK,June 19-21, 2017;2nd World Congress on HumanGenetics, Chicago, USA,July 24-26, 2017;9th International Conference onGenomicsand Pharmacogenomics, London,UK,June 15-16, 2017. 28thAnnual Lorne Genomics Conference2017 February 12-14, 2017 Mantra Lorne, Victoria, Australia.

Related Societies:

Swiss Society of Medical Genetics, Switzerland.Human Variome Project, Australia.American College of Medical Genetics and Genomics, USA.International Federation of Human Genetics Societies, South Africa.Human Genetics Society of Australasia, Australia.Belgian Society for Human Genetics, Belgian.Asia Pacific Society of Human Genetics, Asia.

Track 12:Personal Genomics

Individualgenomicsis the branch of genomics worried with thesequencingand examination of the genome of a person. Thegenotypingstage utilizes diverse strategies, includingsingle-nucleotide polymorphism(SNP) examination chips or incomplete or fullgenome sequencing.

RelatedConferences:

7th International Conference onPlantGenomics,Bangkok, Thailand,July 03-05, 2017; 15th EuroBiotechnologyCongress,Valencia, Spain,June 05-07, 2017; International Conference onIntegrative Medicine& Nutrition,Dubai, UAE,May11-13, 2017; 14th Asia-PacificBiotechCongress, April 10-12, 2017; Beijing, China,15thBiotechnologyCongress,Baltimore, USA,June 22-23, 2017. 29thFungal Genetics conferenceMarch 14-19, 2017 Pacific Grove, CA.

Related Societies:

International Federation of Human Genetics Societies, South Africa.Europe. Human Genome Organisation, South Korea.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.International Federation of Human Genetics Societies, South Africa.Human Genetics Society of Australasia, Australia.German Society of Human Genetics, Germany.

Track 13:Microbial Genomics

MicrobialGenomicsappliesrecombinantDNA,DNAsequencingroutines,andbioinformaticsto succession, gather, and dissect the capacity and structure of genomes in organisms. Amid the previous 10 years, genomics-based methodologies have profoundly affected the field ofmicrobiologyand our comprehension of microbial species. In view of their bigger genome sizes,genome sequencingendeavors on growths and unicellular eukaryotes were slower to begin than ventures concentrated on prokaryotes.

RelatedConferences:

5th International Conference and Exhibition onCell and Gene Therapy,Madrid, Spain, Mar 2-3, 2017;International Conference onCell Signalling andCancer Therapy,Paris, France,Aug 20-22, 2017; 7th Annual Conference onStem Celland Regenerative Medicine,Paris, France,Aug 04-05, 2016;3rd International Conference & Exhibition onTissue Preservationand Bio banking,Baltimore, USA,June 29-30, 2017.Internation Plant and Animal Conference XXVJanuary 14-18, 2017 San Diego, CA, USA.

Related Societies:

Canadian Association of Genetic Counsellors, Canada.European Cytogeneticists Association, Europe.Human Genome Organisation, South Korea.Biochemistry Moroccan Society and Molecular Biology, Africa,Federation of African societies of Biochemistry & Molecular Biology, Kenya.South African Stem Cell Transplantation Society, South Africa.National Society of Genetic Counselors, Chicago.Canadian College of Medical Geneticists, Canada.German Society of Human Genetics, Germany.

Track 14:Future trends in Genomics

Genomics researchholds the way to meeting a considerable lot of the difficulties of the coming years. Right now, the greatest test is in information investigation. We can produce a lot of information modestly, yet that overpowers our ability to comprehend it. The significant test of theGenomeResearch is we have to imbuegenomic datainto restorative practice, which is truly hard.

RelatedConferences:

6th International Conference onTissue Engineering &Regenerative Medicine,Baltimore, USA,Aug 20-22, 2017; 8th World Congress and Expo onCell &Stem Cell Research,Orlando, USA,March 20-22, 2017; 15thWorld Congress onBiotechnologyand Biotech Industries Meet,Rome, Italy,March 20-21, 2017; 2nd International Conference onGenetic Counselling andGenomic Medicine,Beijing, China, July 10-12, 2017; International Conference onClinical andMolecular Genetics,Las Vegas, USA,April 24-26, 2017.Internation Plant and Animal Conference XXVJanuary 14-18, 2017 San Diego, CA, USA.Plant Genomics and Gene Editing CongressConference Asia April 10-11, 2017 Hong Kong.

Related Societies:

Originally posted here:
Worlds Leading Genomics Conference | Global Meetings ...

Researchers from Vrije Universiteit Amsterdam and elsewhere have identified seven risk genes for insomnia.

Insomnia is one of the most common health problems. Image credit: Dan Fa.

Insomnia is among the most frequent complaints in general practice. Even after treatment, poor sleep remains a persistent vulnerability for many people.

A research team led by Vrije Universiteit Professor Danielle Posthuma has come closer to unraveling the biological mechanisms that cause the predisposition for insomnia.

Our findings are the start of a path towards an understanding of insomnia at the level of communication within and between neurons, and thus towards finding new ways of treatment, Vrije Universiteit Professor Van Someren, co-author of the study.

As compared to the severity, prevalence and risks of insomnia, only few studies targeted its causes. Insomnia is all too often dismissed as being all in your head. Our research brings a new perspective. Insomnia is also in the genes.

To identify genetic factors for insomnia complaints, Prof. Posthuma, Prof. Someren and their colleagues performed a genome-wide association study and a genome-wide gene-based association study in 113,006 individuals.

As a result, the researchers identified seven genes associated with insomnia.

These genes play a role in the regulation of transcription, the process where DNA is read in order to make an RNA copy of it, and exocytosis, the release of molecules by cells in order to communicate with their environment, the authors said.

One of the identified genes, MEIS1, has previously been related to two other sleep disorders: periodic limb movements of sleep (PLMS) and restless legs syndrome (RLS).

Variants in the MEIS1 gene seem to contribute to all three disorders, they added.

Strikingly, PLMS and RLS are characterized by restless movement and sensation, respectively, whereas insomnia is characterized mainly by a restless stream of consciousness.

The team also found a strong genetic overlap with other traits, such as anxiety disorders, depression and neuroticism, and low subjective wellbeing.

This is an interesting finding, because these characteristics tend to go hand in hand with insomnia, said study first author Anke Hammerschlag, a PhD student at Vrije Universiteit.

We now know that this is partly due to the shared genetic basis.

The researchers also studied whether the same genetic variants were important for men and women.

Part of the genetic variants turned out to be different. This suggests that, for some part, different biological mechanisms may lead to insomnia in men and women, Prof. Posthuma said.

We also found a difference between men and women in terms of prevalence: in the sample we studied, including mainly people older than fifty years, 33% of the women reported to suffer from insomnia. For men this was 24%.

The teams findings were published today in the journal Nature Genetics.

_____

Anke R. Hammerschlag et al. Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits. Nature Genetics, published online June 12, 2017; doi: 10.1038/ng.3888

Read more:
Scientists Discover First Genes for Insomnia - Sci-News.com

LOS ANGELES, June 12, 2017 /PRNewswire/ --B-Real, DNA Genetics and PRHBTD Media,have joined forces to produce a new digital first reality series titled, "Pimp My Grow," aimed at cannabis enthusiasts.

DNA Genetics, one of the oldest and most respected genetics and grow experts in the Cannabis industry will visit Cannabis growers around the country and "Pimp Their Grows."Some growers may be new to the industry, looking to set-up their first personal grow for medical reasons, while others are building out industrial-sized indoor operations. All of them have one thing in common; they are looking to harness DNA's best-in-class expertise.

"We're psyched to meet with amateurs as well as experienced growers to help them grow the biggest, healthiest and most special plants!And we're going to bring along a few of our friends to help out," said DNA's Don/Aaron.

B-Real added, "I've seen a ton of good and bad growers and grows in this space. Nothing compares to the work that the DNA guys do.They will literally pimp out some grows.This is going to be unreal and unprecedented."

See more at http://www.prohbtd.com/pimpmygrow.

Drake Sutton-Shearer and Josh Otten from PRHBTD Media added, "Viewers will experience the thrill of growing with some of the best technology available. DNA and B-Real are experts in what they do, so it's a pleasure for us to help them show the world just what it takes to pimp out a grow."

The completed video series will result in seven episodes that showcase each grow operationand the hosts' expertise in helping each grower with their set-up.The series will initially be distributed across the PRHBTD MEDIA network to millions of viewers and then licensed for global content distribution.

B-Real and DNA Genetics will be working with some of their friends to provide product and service support when optimizing each grow. From lighting and nutrients to harvesting and storage, these world-class companies offer some of the best products and services on the market to ensure the highest quality plants and yield.

Added Greg Muller, CEO of leading LED lighting company Spectrum King: "We're excited to be a part of this series and work with these cannabis industry leaders to help show audiences how our technology can help increase potency yield and significant cost savings for growers."

Learn more atwww.prohbtd.com/pimpmygrow

About B-REAL

With his work in the pioneering hip-hop group Cypress Hill, rapper B-Real became something of a hip-hop legend for several reasons. Most immediately, his trademark rhyming style, featuring an exaggeratedly nasal whine and a jazz singer's skill at staying just behind DJ Muggs' already sluggish beats, was one of the most instantly recognizable flows of the 1990s. Furthermore, B-Real and his partners Sen Dog and DJ Muggs were the first Latino hip-hop stars, ushering in a richly varied sub-genre of hip-hop that thrives to this day. Finally, Cypress Hill's fervent proselytizing on the subject of marijuana legalization both brought the subject to its highest public awareness since the days of Cheech & Chong and paved the way for a generation of weed-happy middle-class high-school kids to discover and identify with hip-hop to an even greater degree than before.

About DNA Genetics

DNA Genetics, one of the most important seed companies in the world, has been at the forefront of the cannabis industry and culture for over a decade.DNA has won more than 150 awards worldwide at the most prestigious events and trade shows for their contributions to the cannabis industry, making it the most-awarded company in the world. DNA has won the illustrious High Times 'Top 10 Strain of the Year' award more than five times, is the only seed company to have received every award presented at the High Times Cannabis Cup events and was inducted into the High Times Seedbank Hall of Fame in 2009. Working with the medical and scientific community has been a priority, helping to provide alternative solutions to the current pharmaceutical approach. Collaborations with the Unconventional Foundation for Autism and Israeli Research are some of the examples. DNA Genetics is also very proud of their new partnership with Canadian Licensed Medical Producers, Tweed in Ontario, Canada. When working within the medical community, DNA Genetics is committed not only to effective medicine, but also to combining all beneficial parts of the plant for a better experience and more effective results for the patients.

About PRHBTD MEDIA

PRHBTD MEDIA provides world-class video production, digital marketing and branding solutions for more than 50 brand partners in the cannabis industry. As the leading content studio, PRHBTD also produces original video and editorial with multi-platform distribution across the PRHBTD Media Network, which includes prohbtd.com, AppleTV, Amazon Prime, Roku, Metacafe, Dailymotion and more, reaching 100+ million monthly consumers and business owners.

To learn more, contact whatsgood@prohbtd.com

Media Contact: handsonpr@aol.com

Related Images

image1.jpg

image2.png

image3.png

image4.png

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/b-real-dna-genetics-and-prohbtd-media-announce-digital-first-reality-series-pimp-my-grow-300472088.html

SOURCE PROHBTD

Read more from the original source:
B-Real, DNA Genetics and PRHBTD Media Announce Digital-First Reality Series, 'Pimp My Grow' - PR Newswire (press release)